Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin.

Blood Res

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Published: December 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705052PMC
http://dx.doi.org/10.5045/br.2015.50.4.254DOI Listing

Publication Analysis

Top Keywords

complete remission
4
remission cd30-positive
4
cd30-positive refractory
4
refractory extranodal
4
extranodal nk/t-cell
4
nk/t-cell lymphoma
4
lymphoma brentuximab
4
brentuximab vedotin
4
complete
1
cd30-positive
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!